These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 23711358)

  • 61. The levonorgestrel intrauterine system: more than a contraceptive.
    Andersson K
    Eur J Contracept Reprod Health Care; 2001; 6 Suppl 1():15-22. PubMed ID: 25104510
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders.
    Schaedel ZE; Dolan G; Powell MC
    Am J Obstet Gynecol; 2005 Oct; 193(4):1361-3. PubMed ID: 16202726
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic/inhibitor systems in women with menorrhagia.
    Koh SC; Singh K
    J Thromb Haemost; 2007 Jan; 5(1):133-8. PubMed ID: 17010149
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Patient satisfaction for levonorgestrel intrauterine system and norethisterone for treatment of dysfunctional uterine bleeding.
    Naqaish T; Rizvi F; Khan A; Afzal M
    J Ayub Med Coll Abbottabad; 2012; 24(1):23-6. PubMed ID: 23855088
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of two cohorts of women who expulsed either a copper-intrauterine device or a levonorgestrel-releasing intrauterine system.
    Simonatto P; Bahamondes MV; Fernandes A; Silveira C; Bahamondes L
    J Obstet Gynaecol Res; 2016 May; 42(5):554-9. PubMed ID: 26817571
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders.
    Kingman CE; Kadir RA; Lee CA; Economides DL
    BJOG; 2004 Dec; 111(12):1425-8. PubMed ID: 15663130
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Use of the levonorgestrel-IUD in the treatment of menorrhagia: improving patient outcomes while reducing the need for surgical management.
    Kaunitz AM; Stern L; Doyle J; Etschmaie MR
    Manag Care Interface; 2007 Mar; 20(3):47-50. PubMed ID: 17458481
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A randomized prospective trial comparing the levonorgestrel-releasing intrauterine system with thermal balloon ablation for the treatment of heavy menstrual bleeding.
    de Souza SS; Camargos AF; de Rezende CP; Pereira FA; Araújo CA; Silva Filho AL
    Contraception; 2010 Mar; 81(3):226-31. PubMed ID: 20159179
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas.
    Bahamondes MV; Hidalgo MM; Bahamondes L; Monteiro I
    Contraception; 2011 Nov; 84(5):e11-6. PubMed ID: 22018132
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Combined Endometrial Ablation and Levonorgestrel Intrauterine System Use in Women With Dysmenorrhea and Heavy Menstrual Bleeding: Novel Approach for Challenging Cases.
    Papadakis EP; El-Nashar SA; Laughlin-Tommaso SK; Shazly SA; Hopkins MR; Breitkopf DM; Famuyide AO
    J Minim Invasive Gynecol; 2015; 22(7):1203-7. PubMed ID: 26122898
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS).
    Heikinheimo O; Gemzell-Danielsson K
    Acta Obstet Gynecol Scand; 2012 Jan; 91(1):3-9. PubMed ID: 22007693
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Progestin-releasing intrauterine systems and leiomyoma.
    Kaunitz AM
    Contraception; 2007 Jun; 75(6 Suppl):S130-3. PubMed ID: 17531604
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Subject and clinician experience with the levonorgestrel-releasing intrauterine system.
    Jensen JT; Nelson AL; Costales AC
    Contraception; 2008 Jan; 77(1):22-9. PubMed ID: 18082662
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia.
    Sayed GH; Zakherah MS; El-Nashar SA; Shaaban MM
    Int J Gynaecol Obstet; 2011 Feb; 112(2):126-30. PubMed ID: 21092958
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.
    Wildemeersch D; Janssens D; Vrijens M; Weyers S
    Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138
    [TBL] [Abstract][Full Text] [Related]  

  • 76. One year quality of life measured with SEC-QoL in levonorgestrel 52 mg IUS users.
    Cristobal I; Lete LI; Viuda E; Perulero N; Arbat A; Canals I
    Contraception; 2016 Apr; 93(4):367-371. PubMed ID: 26764120
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Management of menorrhagia in women with inherited bleeding disorders: general principles and use of desmopressin.
    Rodeghiero F
    Haemophilia; 2008 Jan; 14 Suppl 1():21-30. PubMed ID: 18173691
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Therapeutic use of the LNG IUS, and counseling.
    Pakarinen P; Toivonen J; Luukkainen T
    Semin Reprod Med; 2001 Dec; 19(4):365-72. PubMed ID: 11727178
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The cost-effectiveness of the levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding in the United States.
    Ganz ML; Shah D; Gidwani R; Filonenko A; Su W; Pocoski J; Law A
    Value Health; 2013; 16(2):325-33. PubMed ID: 23538185
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Predictors of bleeding and user satisfaction during consecutive use of the levonorgestrel-releasing intrauterine system.
    Heikinheimo O; Inki P; Kunz M; Gemzell-Danielsson K
    Hum Reprod; 2010 Jun; 25(6):1423-7. PubMed ID: 20378611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.